Clinical, epidemiological, and drug resistance insights into HIV-positive patients in Meizhou, China.

Publication Year: 2024

DOI:
10.3389/fcimb.2023.1330826

PMCID:
PMC10835272

PMID:
38314093

Journal Information

Full Title: Front Cell Infect Microbiol

Abbreviation: Front Cell Infect Microbiol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Communicable Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."

Evidence found in paper:

"The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This study was supported by Guangdong Provincial Key Laboratory of Precision Medicine and Clinical Translation Research of Hakka Population (2018B030322003), Science and Technology Program of Guangzhou (20220600114), Science and Technology Program of Meizhou (2019B0202001, 2019B001), Shenzhen Fund for Guangdong Provincial High-Level Clinical Key Specialties (No. SZGSP012), Shenzhen Key Medical Discipline Construction Fund (No. SZXK034)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025